Signal from the log
MaxQ Medical
31,5 M$ · Series A · United States · Medtech
Société de Sunnyvale qui développe un système transurétral réunissant l'imagerie par ultrasons et le traitement du tissu prostatique en une seule intervention. Première indication l'hyperplasie bénigne de la prostate, puis la thérapie focale du cancer. Premier essaimage d'Orchard Ultrasound Innovation.
Verified
Announced on , logged by the watch of 20 August 2026.
- Operation
- Funding round
- Announced amount
- 31,5 M$
- Stage
- Series A
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Atlantic Blue Ventures , S3 Ventures , Olympus Innovation Ventures
Provenance
Source prnewswire
Logged on 20 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.